Educational
leadership
Belgian universities are among the best in the world, maintaining the scientific standards over time to continue educating the visionary biotech and biopharma leaders of the future.
Twelve leading universities
Belgium is home to 12 universities, featuring internationally renowned life science and innovation departments and research teams. Some are in the top 10 worldwide.
The presence of so many high quality universities also ensures a solid educational base and a stable influx of highly educated and productive employees.
With Vaccinopolis, we put Belgium on the map. What truly makes our vaccine research center unique is the ability to conduct CHIM (Controlled Human Infection Model) studies. In these studies, volunteers are vaccinated and exposed to a specific pathogen to determine if the candidate vaccines are effective. There is no comparable facility of this magnitude on the European mainland.
Specialists in Life Sciences
The Belgian ecosystem is educating and training talent to guarantee the long-term employability of students in an ever-evolving life science landscape. Future-proof skills are central to every study programme at universities of applied sciences all over the country.
With their future-oriented education and research in life sciences, universities of applied sciences are more than ever a catalyst for innovation. Hands-on solutions for real challenges, that is their trademark. At Thomas More, we’re particularly proud of what we do – and who we educate – in the field of biotech and bioeconomy for a more sustainable future. Our flagship, and rightly so.
Solvay Brussels School’s 2021-2026 strategic plan entitled “We are Ernest” included in its top priorities the creation of the Advanced Master in New Biotech & Medtech Ventures. The latter focuses on the lifecycle of a typical biotech start-up, from science-based innovation to trade sales or IPO. It gathers a truly international cohort of students who are trained by a pool of industry experts and leaders... along the line of our historic values and focus.
World-class university hospitals
Seven university hospitals, some among the best in the world, work in close partnership with the universities. Combining high quality healthcare with pioneering scientific research, they deliver the best possible levels of care to every patient.
From a University Hospitals and Clinical Trial Center (CTC) perspective, the R&D Bioplatform initiative is an ideal forum to emphasize the importance and dynamism of academic clinical research in Belgium. University hospitals are major players in the conduct of clinical trials/experiments through their clinical excellence and their scientific commitment. As central points of contact at our respective clinical research sites, we, as CTCs, are ideally placed to emphasize to all parties involved (i.e. ECs, FAMHP, sponsors, CROs) the need and benefit of collaboration, especially when timelines and patient recruitment are at stake. Two main concerns of the R&D Bioplatform initiative. Herein lies the added value of involving the RUZB-CHAB CTCs, as a partner, in the further development of the R&D Bioplatform initiative.
Dominique Van Ophem (Cliniques universitaires Saint-Luc),
Catherine De Greef (UZ Brussel),
Heidi Sterckx (UZ Leuven),
Iris Verhaegen (UZA),
Anja Volders (CHU Liège),
Philippe Van Rompaey (UZ Gent)
